Reticuloendothelial system cell in lymph node (RES cell (lymph node))

The reticuloendothelial system (RES) refers to a dispersed group of cells—primarily macrophages, monocytes, and specialized endothelial cells—found throughout the body in organs such as the liver, spleen, bone marrow, and especially lymph nodes[1][2][5][6]. These cells are powerful phagocytes that play several essential roles, including engulfing pathogens and particulates, presenting antigens to lymphocytes to initiate immune responses, processing cellular debris, and recycling iron from aged red blood cells[1][2][4][5][6]. In the lymph nodes, RES cells serve as immune sentinels and are involved in filtering lymph to clear foreign materials and initiate adaptive immunity. The term encompasses a broad, somewhat outdated histological classification; more precise modern classification refers to them as "macrophages" or elements of the "mononuclear phagocyte system"[2][3][4]. They are not themselves a molecular drug target—rather, they are a heterogeneous population of immune cells. Clarification of accuracy and completeness: - The name "Reticuloendothelial system cells in lymph nodes" is not a canonical molecule or receptor but refers to a group of immune cells in anatomical context. It describes a cell population, not a defined molecular entity or therapeutic target. - For molecular targeting, specific surface markers (such as CD68 or CD163) are used, but "reticuloendothelial system cell" is not itself a target. - No directly interacting drugs or defined mechanism of action are applicable to this entire cell class. - Therefore, entries such as interacting_drugs, mechanism_of_action, and safety_concerns are set to "null," and "is_incorrect" is set to true to indicate that this is not a proper molecular target name for structured drug discovery contexts.

Other names

Mononuclear phagocyte (lymph node)Macrophage (lymph node)Lymphoreticular cellMonocyte-macrophage system cellScavenger endothelial cell (rare/obsolete usage)